A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome
for Short Bowel Syndrome
Sites in San Francisco, Palo Alto +4 more locations
Sponsor: Eclipse Regenesis, Inc.
Sex: All·Age: 3 Months - 65
Code: NCT05535361·Recruiting·Listed Sep 2022